Qu Yafei, Wang Xin, Zhu Yunkai, Wang Weili, Wang Yuyan, Hu Gaowei, Liu Chengrong, Li Jingjiao, Ren Shanhui, Xiao Maggie Z X, Liu Zhenshan, Wang Chunxia, Fu Joyce, Zhang Yucai, Li Ping, Zhang Rong, Liang Qiming
Research Center of Translational Medicine, Shanghai Institute of Immunology, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Science, Shanghai Medical College, Biosafety Level 3 Laboratory, Fudan University, Shanghai, China.
Front Cell Dev Biol. 2021 Jul 27;9:716208. doi: 10.3389/fcell.2021.716208. eCollection 2021.
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative agent for the coronavirus disease 2019 (COVID-19) pandemic and there is an urgent need to understand the cellular response to SARS-CoV-2 infection. Beclin 1 is an essential scaffold autophagy protein that forms two distinct subcomplexes with modulators Atg14 and UVRAG, responsible for autophagosome formation and maturation, respectively. In the present study, we found that SARS-CoV-2 infection triggers an incomplete autophagy response, elevated autophagosome formation but impaired autophagosome maturation, and declined autophagy by genetic knockout of essential autophagic genes reduces SARS-CoV-2 replication efficiency. By screening 26 viral proteins of SARS-CoV-2, we demonstrated that expression of ORF3a alone is sufficient to induce incomplete autophagy. Mechanistically, SARS-CoV-2 ORF3a interacts with autophagy regulator UVRAG to facilitate PI3KC3-C1 (Beclin-1-Vps34-Atg14) but selectively inhibit PI3KC3-C2 (Beclin-1-Vps34-UVRAG). Interestingly, although SARS-CoV ORF3a shares 72.7% amino acid identity with the SARS-CoV-2 ORF3a, the former had no effect on cellular autophagy response. Thus, our findings provide the mechanistic evidence of possible takeover of host autophagy machinery by ORF3a to facilitate SARS-CoV-2 replication and raise the possibility of targeting the autophagic pathway for the treatment of COVID-19.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是2019冠状病毒病(COVID-19)大流行的病原体,因此迫切需要了解细胞对SARS-CoV-2感染的反应。Beclin 1是一种重要的自噬支架蛋白,它与调节因子Atg14和UVRAG形成两个不同的亚复合物,分别负责自噬体的形成和成熟。在本研究中,我们发现SARS-CoV-2感染引发了不完全的自噬反应,自噬体形成增加但自噬体成熟受损,通过对必需自噬基因进行基因敲除降低自噬水平可降低SARS-CoV-2的复制效率。通过筛选SARS-CoV-2的26种病毒蛋白,我们证明仅ORF3a的表达就足以诱导不完全自噬。从机制上讲,SARS-CoV-2的ORF3a与自噬调节因子UVRAG相互作用,促进PI3KC3-C1(Beclin-1-Vps34-Atg14)的形成,但选择性抑制PI3KC3-C2(Beclin-1-Vps34-UVRAG)。有趣的是,尽管SARS-CoV的ORF3a与SARS-CoV-2的ORF3a有72.7%的氨基酸同一性,但前者对细胞自噬反应没有影响。因此,我们的研究结果提供了机制证据,证明ORF3a可能接管宿主自噬机制以促进SARS-CoV-2复制,并提高了靶向自噬途径治疗COVID-19的可能性。